Clinical trial
Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
NCT00444665 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
- Lead sponsor
- Alcon Research
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- August 31, 2007
- Enrollment
- 750 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.